NSE - Delayed Quote INR
SENORES PHARMACEUTICALS L (SENORES.NS)
517.05
-15.45
(-2.90%)
At close: April 25 at 3:29:55 PM GMT+5:30
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 24.99M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.48 per share. | Direct | 3,561 | Mar 12, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.45 per share. | Direct | 6,448 | Feb 25, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.37 per share. | Direct | 9,146 | Feb 24, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.00 per share. | Direct | 204 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 6 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 174 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 60 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 1,790 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 120 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 2,753 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 222 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 456 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 276 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 138 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 853 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 2,043 | Feb 19, 2025 |
Shah (Chetan Bipinchandra) Director | Acquisition at price 6.01 per share. | Direct | 2,517 | Feb 19, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.26 per share. | Direct | 200 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 17,812 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.26 per share. | Direct | 6 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.26 per share. | Direct | 237 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 18,864 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.26 per share. | Direct | 3,300 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.26 per share. | Direct | 112 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.26 per share. | Direct | 6 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 948 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 2,343 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 146 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 286 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 388 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 414 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 522 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 1,146 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 242 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 63 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 2,536 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 2,018 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.37 per share. | Direct | 6 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.26 per share. | Direct | 2,843 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.26 per share. | Direct | 4,246 | Feb 13, 2025 |
Majmudar (Sanjay Shaileshbhai) Director | Acquisition at price 6.26 per share. | Direct | 17,975 | Feb 13, 2025 |
Parikh (Jeshika Hiten) UNREPORTED | Acquisition at price 6.09 per share. | Direct | 499 | Feb 12, 2025 |
Parikh (Jeshika Hiten) UNREPORTED | Acquisition at price 6.09 per share. | Direct | 11,202 | Feb 12, 2025 |
Parikh (Jeshika Hiten) UNREPORTED | Acquisition at price 6.08 per share. | Direct | 11,475 | Feb 12, 2025 |
Parikh (Jeshika Hiten) UNREPORTED | Acquisition at price 6.07 per share. | Direct | 12,043 | Feb 12, 2025 |
Parikh (Jeshika Hiten) UNREPORTED | Acquisition at price 6.08 per share. | Direct | 164 | Feb 12, 2025 |
Parikh (Jeshika Hiten) UNREPORTED | Acquisition at price 6.09 per share. | Direct | 24 | Feb 12, 2025 |
Parikh (Jeshika Hiten) UNREPORTED | Acquisition at price 6.09 per share. | Direct | 383 | Feb 12, 2025 |
Parikh (Jeshika Hiten) UNREPORTED | Acquisition at price 6.09 per share. | Direct | 1,759 | Feb 12, 2025 |
Parikh (Jeshika Hiten) UNREPORTED | Acquisition at price 6.09 per share. | Direct | 5,612 | Feb 12, 2025 |
Related Tickers
MARKSANS.NS Marksans Pharma Limited
216.03
-5.40%
DSNKY Daiichi Sankyo Company, Limited
24.85
+0.44%
NVS Novartis AG
112.14
+0.87%
AMGN Amgen Inc.
280.84
+0.36%
GILD Gilead Sciences, Inc.
103.17
-2.81%
NVO Novo Nordisk A/S
62.08
-0.88%
BMY Bristol-Myers Squibb Company
47.90
-1.62%
MRK Merck & Co., Inc.
82.74
+3.63%
PFE Pfizer Inc.
22.92
+0.61%
LLY Eli Lilly and Company
884.54
+2.89%